() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Sunniva Receives Confirmation of Readiness from Health Canada

Sunniva Receives Confirmation of Readiness from Health Canada

Vancouver, British Columbia--(Newsfile Corp. - May 29, 2018) - Sunniva Inc. (CSE:SNN) (OTCQX: SNNVF) ("Sunniva" or the "Company"), a North American provider of cannabis products and services, is pleased to announce a major milestone with the receipt from Health Canada of the Confirmation of Readiness ("COR") for a License under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") for the Company's wholly owned subsidiary, Sunniva Medical Inc. ("SMI"). This represents acceptance of our detailed application with the next step being an inspection upon site readiness in order to commence cultivation.

The license and the expected completion of the Sunniva Canada Campus will position the Company as a significant supplier to the rapidly growing Canadian cannabis market. Sunniva previously announced a take or pay supply agreement with Canopy Growth Corporation ("Canopy"). Under the terms of the initial two-year agreement, which includes the distribution of Sunniva branded products, Canopy will purchase approximately 45% of Sunniva's annual production capacity; representing 45,000 kgs of dried cannabis annually, commencing Q1 2019 or shortly thereafter. The agreement is subject to SMI receiving its license from Health Canada and completing the Sunniva Canada Campus.

The Company is also pleased to announce that SMI has received development approval from the Regional District of Okanagan-Similkameen for construction of the Sunniva Canada Campus, which commenced at the beginning of May, on its previously announced purchased 126-acre site in Okanagan Falls, British Columbia. Sunniva is currently finalizing the financing via bank and subordinate debt for the planned state-of-the-art 740,000 sq. ft. facility, designed to meet current Good Manufacturing Practice ("cGMP") standards.

The Company is now focused on building the facility according to the design submitted. Sunniva is leveraging its experience from their flagship greenhouse facility in California, which is already 5 months into the construction cycle. In order to confirm readiness, SMI will be required to submit information including documentation, photos, and videos of the Sunniva Canada Campus presenting evidence of all physical security measures in order to receive a cultivation license from Health Canada.

Sunniva has chosen the following vendors in respect to the Sunniva Canada Campus project:

  • Certhon Projects B.V. – supplier of the greenhouse superstructure, electrical, irrigation systems, lighting system and heating, cooling and CO2 systems.
  • EllisDon Corporation – engineering, construction manager and general contractor.
  • MQN Architects – architect consultant.
  • Urban Systems Ltd. – civil and landscape engineers.

We are pleased to deliver on another key corporate milestone for the Company as we have made an excellent start to 2018 with significant progress on multiple fronts, executing on our strategy, and working toward our goal of creating one of the most efficient, low-cost growing operations to serve the Canadian and California cannabis market," said Dr. Anthony Holler, CEO, Sunniva. "It is our intention to forward sell an additional 30% of our production capacity in Canada

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world's two largest cannabis markets — Canada and California — where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva's management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.


Comments are closed.